Modified liquisolid compacts demonstrated improved dissolution in immediate-release tablet formulations

Dissolution Enhancement of Raloxifene Hydrochloride

Automation offers benefits for sterile manufacturing in 503B facilities. 

Robotics for Drug Compounding

Multiple types of highly potent biologics require specialized manufacturing skills.

Assessing Risk and Production of Potent Substances

Topic

Articles

Sinovac Biotech’s Eupolio vaccine, a Sabin inactivated poliovirus vaccine (sIPV), has gained marketing authorization in China.

Sinovac’s Eupolio Vaccine Gains Market Authorization in China

Specialty pharmaceutical company, Advanz Pharma, has launched a generic version of lanreotide, MYTOLAC, in Germany.

Advanz Pharma Launches Generic Lanreotide in Germany

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Modeling the manufacturing process benefits both development and operations. 

GSK Pilots Digital Twin for Vaccine Manufacturing 

ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.

SAHPRA Authorizes ImmunityBio to Proceed with Trial of T-Cell Vaccine as Booster Against COVID-19

The US federal government awarded new funding to the National Institute for Innovation in Manufacturing Biopharmaceuticals, including funding under the American Rescue Plan that will be used to advance vaccine manufacturing. 

NIIMBL Receives Federal Funding for Biopharmaceutical Manufacturing Projects

The new lab near Continuus Pharmaceutical’s current facilities in Massachusetts will expand the company’s process development capabilities to high-potency drugs.

Continuus Pharmaceuticals Opens Process Development Lab

UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.

SPI Pharma Introduces Platform for Orally Disintegrating Tablets

Tezepelumab, being developed by AstraZeneca in collaboration with Amgen, reduced asthma exacerbations in Phase II and III clinical trials. 

FDA Grants Priority Review for AstraZeneca Asthma Biologic

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Advances in technology are accelerating the development and manufacture of subunit vaccines, an established class of vaccines.

Subunit Vaccines and the Fight Against COVID-19

Susana Saldanha, PharmD, is formulation development scientist at Hovione.

Beatriz Fernandes, MSc, is a formulation development scientist at Hovione

João Ventura, PhD, is director of Technology Development and Licensing at Hovione Technology.

Particle performance in a DPI can be optimized by fine-tuning the formulation and manufacturing process parameters.

Dosage Forms

Dissolution Enhancement of Raloxifene Hydrochloride

Robotics for Drug Compounding

Assessing Risk and Production of Potent Substances